Evidence map›Paper›PMID 39571670›Full record

ArticleInfection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases2024

Surveillance and agnostic capture sequencing of samples from individuals with rash-associated illness in Mali indicates regional transmission of measles virus from West and Central Africa.

Fousseyni Kané, John Collins, Amadou Koné, Noumou Y Keita, Issa Cisse, Klèma M Koné, Dramane Diallo, Issa Konate, Djeneba K Dabitao, Bassirou Diarra and 18 more

Abstract read
In one paragraph

Article in Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Fousseyni KanéUniversity Clinical Research Center (UCRC), Techniques, and Technologies of Bamako (USTTB), Bamako, Mali; Global Alliance for Preventing Pandemics, Columbia University, NY, New York, United States of America. Electronic address: fouskane@icermali.org.
John CollinsCenter for Infection and Immunity, Columbia University, NY, New York, United States of America; Global Alliance for Preventing Pandemics, Columbia University, NY, New York, United States of America.
Amadou KonéUniversity Clinical Research Center (UCRC), Techniques, and Technologies of Bamako (USTTB), Bamako, Mali; Global Alliance for Preventing Pandemics, Columbia University, NY, New York, United States of America.
Noumou Y KeitaNational Institute for Public Health (INSP), Bamako, Mali.
Issa CisseNational Institute for Public Health (INSP), Bamako, Mali.
Klèma M KonéNational Institute for Public Health (INSP), Bamako, Mali.
Dramane DialloUniversity Clinical Research Center (UCRC), Techniques, and Technologies of Bamako (USTTB), Bamako, Mali.
Issa KonateUniversity Clinical Research Center (UCRC), Techniques, and Technologies of Bamako (USTTB), Bamako, Mali.
Djeneba K DabitaoUniversity Clinical Research Center (UCRC), Techniques, and Technologies of Bamako (USTTB), Bamako, Mali.
Bassirou DiarraUniversity Clinical Research Center (UCRC), Techniques, and Technologies of Bamako (USTTB), Bamako, Mali.
Ibrahim SanogoUniversity Clinical Research Center (UCRC), Techniques, and Technologies of Bamako (USTTB), Bamako, Mali.
Tenin A CoulibalyUniversity Clinical Research Center (UCRC), Techniques, and Technologies of Bamako (USTTB), Bamako, Mali.
Mountaga DialloUniversity Clinical Research Center (UCRC), Techniques, and Technologies of Bamako (USTTB), Bamako, Mali.
Daouda KeitaUniversity Clinical Research Center (UCRC), Techniques, and Technologies of Bamako (USTTB), Bamako, Mali.
Cheick O TangaraUniversity Clinical Research Center (UCRC), Techniques, and Technologies of Bamako (USTTB), Bamako, Mali.
Mahamadou DiakitéUniversity Clinical Research Center (UCRC), Techniques, and Technologies of Bamako (USTTB), Bamako, Mali.
Sounkalo DaoUniversity Clinical Research Center (UCRC), Techniques, and Technologies of Bamako (USTTB), Bamako, Mali.
Karine Fouth-TchosCollaborative Clinical Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
Jamila AboulhabCollaborative Clinical Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
Aaron NealCollaborative Clinical Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
Kathryn Shaw-SalibaCollaborative Clinical Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
Xiang-Jun LuCenter for Infection and Immunity, Columbia University, NY, New York, United States of America; Global Alliance for Preventing Pandemics, Columbia University, NY, New York, United States of America.
Thomas BrieseCenter for Infection and Immunity, Columbia University, NY, New York, United States of America; Global Alliance for Preventing Pandemics, Columbia University, NY, New York, United States of America; Department of Epidemiology, Mailman School of Public Health, Columbia University, NY, New York, United States of America.
W Ian LipkinCenter for Infection and Immunity, Columbia University, NY, New York, United States of America; Global Alliance for Preventing Pandemics, Columbia University, NY, New York, United States of America; Department of Epidemiology, Mailman School of Public Health, Columbia University, NY, New York, United States of America; Departments of Neurology, and of Pathology and Cell Biology, College of Physicians and Surgeons, Columbia University, NY, New York, United States of America.
Ibrehima GuindoNational Institute for Public Health (INSP), Bamako, Mali.
Ray Y ChenCollaborative Clinical Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
J Kenneth WickiserCenter for Infection and Immunity, Columbia University, NY, New York, United States of America; Global Alliance for Preventing Pandemics, Columbia University, NY, New York, United States of America; Department of Population and Family Health, Mailman School of Public Health, Columbia University, NY, New York, United States of America.
Seydou DoumbiaUniversity Clinical Research Center (UCRC), Techniques, and Technologies of Bamako (USTTB), Bamako, Mali.

Funding

WORK ORDER 126643 B539 EXPAND IC SUITE75N91019D00024 · NIAID · LEIDOS BIOMEDICAL RESEARCH, INC. · PI BRISCOE, LYNN · 2019 to 2025
$3932.6M
Mali-Guinea Emerging Infectious Disease Research Training Program (Mali-Guinea EID-RTP)D43TW011818 · FIC · UNIV OF SCIENCES, TECH & TECH OF BAMAKO · PI SEYDOU DOUMBIA · 2022 to 2026
$1.2M
FIC NIH HHS D43 TW011818NCI NIH HHS 75N91019D00024
6 · The paper itself

Abstract

Measles is vaccine-preventable extremely contagious disease caused by the measles virus. High vaccination coverage is needed to prevent outbreaks of disease. Although molecular surveillance of measles is critical to characterize outbreaks and track viral evolution, few whole-genome sequences of measles virus from West Africa are available despite continual outbreaks in the region. Using VirCapSeq-VERT, an enhanced and comprehensive metagenomic sequencing technique that allows for simultaneous identification of all vertebrate viruses, 23 wild-type near-complete genomes of measles virus from across Mali were obtained from samples collected between January 2012 to October 2022. Other febrile rash illnesses were also identified by VirCapSeq-VERT, demonstrating the advantage of using broad detection agnostic methods when the clinical diagnosis is unclear. Whereas one measles virus sequence was consistent with measles vaccine-associated rash illness (VARI), the remaining 38 were classified within the B3.1 genotype. Broad surveillance throughout Mali reveals regional measles virus transmission across West and Central Africa into Mali, while local clinical testing in Bamako shows stable sequence conservation within genotype B3.1 evolving from Nigerian sequences. The genomic information generated in this study is critical in addressing the lack of whole genome sequences available in West Africa and these findings show the importance of phylogenetically tracking measles outbreaks given recent increases in measles cases globally.

Indexed as

ExanthemaMeaslesMeasles virusPhylogenyAdolescentChildChild, PreschoolDisease OutbreaksFemaleGenome, ViralGenotypeHumansInfantMaleMaliGenomeMaliMeaslesPhylogeny

Identifiers

PMID39571670
PMCPMC11833664

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.